vs

Side-by-side financial comparison of Ascendis Pharma A/S (ASND) and Ranger Energy Services, Inc. (RNGR). Click either name above to swap in a different company.

Ascendis Pharma A/S is the larger business by last-quarter revenue ($267.3M vs $142.2M, roughly 1.9× Ranger Energy Services, Inc.). On growth, Ascendis Pharma A/S posted the faster year-over-year revenue change (42.3% vs -0.6%). Over the past eight quarters, Ascendis Pharma A/S's revenue compounded faster (60.7% CAGR vs 1.9%).

Growth hormone therapy refers to the use of growth hormone (GH) as a prescription medication—it is one form of hormone therapy. Growth hormone is a peptide hormone secreted by the pituitary gland that stimulates growth and cell reproduction. In the past, growth hormone was extracted from human pituitary glands. Growth hormone is now produced by recombinant DNA technology and is prescribed for a variety of reasons. GH therapy has been a focus of social and ethical controversies for 50 years.

Ranger Energy Services, Inc. is a leading North American onshore oilfield services provider. It offers a full suite of well completion, workover, rig operations, and production enhancement solutions for upstream oil and gas operators, primarily serving active unconventional shale and tight resource basins across the continental United States.

ASND vs RNGR — Head-to-Head

Bigger by revenue
ASND
ASND
1.9× larger
ASND
$267.3M
$142.2M
RNGR
Growing faster (revenue YoY)
ASND
ASND
+42.9% gap
ASND
42.3%
-0.6%
RNGR
Faster 2-yr revenue CAGR
ASND
ASND
Annualised
ASND
60.7%
1.9%
RNGR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASND
ASND
RNGR
RNGR
Revenue
$267.3M
$142.2M
Net Profit
$3.2M
Gross Margin
90.5%
Operating Margin
2.3%
Net Margin
2.3%
Revenue YoY
42.3%
-0.6%
Net Profit YoY
-44.8%
EPS (diluted)
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASND
ASND
RNGR
RNGR
Q4 25
$267.3M
$142.2M
Q3 25
$230.7M
$128.9M
Q2 25
$170.7M
$140.6M
Q1 25
$109.0M
$135.2M
Q4 24
$187.8M
$143.1M
Q3 24
$62.5M
$153.0M
Q2 24
$38.9M
$138.1M
Q1 24
$103.6M
$136.9M
Net Profit
ASND
ASND
RNGR
RNGR
Q4 25
$3.2M
Q3 25
$-65.9M
$1.2M
Q2 25
$-42.0M
$7.3M
Q1 25
$-102.2M
$600.0K
Q4 24
$5.8M
Q3 24
$-107.1M
$8.7M
Q2 24
$-118.1M
$4.7M
Q1 24
$-141.5M
$-800.0K
Gross Margin
ASND
ASND
RNGR
RNGR
Q4 25
90.5%
Q3 25
89.5%
Q2 25
80.1%
Q1 25
82.6%
Q4 24
91.9%
Q3 24
80.6%
Q2 24
68.2%
Q1 24
92.1%
Operating Margin
ASND
ASND
RNGR
RNGR
Q4 25
2.3%
Q3 25
5.1%
2.0%
Q2 25
-33.5%
6.1%
Q1 25
-103.2%
0.7%
Q4 24
6.2%
Q3 24
-167.3%
8.4%
Q2 24
-370.2%
5.3%
Q1 24
-51.2%
-0.4%
Net Margin
ASND
ASND
RNGR
RNGR
Q4 25
2.3%
Q3 25
-28.5%
0.9%
Q2 25
-24.6%
5.2%
Q1 25
-93.7%
0.4%
Q4 24
4.1%
Q3 24
-171.5%
5.7%
Q2 24
-303.9%
3.4%
Q1 24
-136.6%
-0.6%
EPS (diluted)
ASND
ASND
RNGR
RNGR
Q4 25
$0.14
Q3 25
$0.05
Q2 25
$0.32
Q1 25
$0.03
Q4 24
$0.24
Q3 24
$0.39
Q2 24
$0.21
Q1 24
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASND
ASND
RNGR
RNGR
Cash + ST InvestmentsLiquidity on hand
$665.3M
$10.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-175.8M
$300.1M
Total Assets
$1.4B
$419.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASND
ASND
RNGR
RNGR
Q4 25
$665.3M
$10.3M
Q3 25
$582.2M
$45.2M
Q2 25
$533.6M
$48.9M
Q1 25
$559.4M
$40.3M
Q4 24
$604.3M
$40.9M
Q3 24
$675.6M
$14.8M
Q2 24
$279.4M
$8.7M
Q1 24
$345.9M
$11.1M
Total Debt
ASND
ASND
RNGR
RNGR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
$0
Q2 24
$0
Q1 24
$0
Stockholders' Equity
ASND
ASND
RNGR
RNGR
Q4 25
$-175.8M
$300.1M
Q3 25
$-188.0M
$270.0M
Q2 25
$-202.6M
$276.9M
Q1 25
$-205.0M
$272.6M
Q4 24
$-114.2M
$273.8M
Q3 24
$-105.1M
$267.6M
Q2 24
$-346.8M
$260.5M
Q1 24
$-257.2M
$261.7M
Total Assets
ASND
ASND
RNGR
RNGR
Q4 25
$1.4B
$419.3M
Q3 25
$1.2B
$372.8M
Q2 25
$1.2B
$381.7M
Q1 25
$1.1B
$376.5M
Q4 24
$1.3B
$381.6M
Q3 24
$1.2B
$373.9M
Q2 24
$819.0M
$359.6M
Q1 24
$866.7M
$355.5M
Debt / Equity
ASND
ASND
RNGR
RNGR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASND
ASND
RNGR
RNGR
Operating Cash FlowLast quarter
$58.2M
$24.1M
Free Cash FlowOCF − Capex
$17.1M
FCF MarginFCF / Revenue
12.0%
Capex IntensityCapex / Revenue
4.9%
Cash ConversionOCF / Net Profit
7.53×
TTM Free Cash FlowTrailing 4 quarters
$42.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASND
ASND
RNGR
RNGR
Q4 25
$58.2M
$24.1M
Q3 25
$13.6M
Q2 25
$20.7M
Q1 25
$-15.5M
$10.6M
Q4 24
$-330.7M
$32.7M
Q3 24
$17.7M
Q2 24
$22.1M
Q1 24
$-109.7M
$12.0M
Free Cash Flow
ASND
ASND
RNGR
RNGR
Q4 25
$17.1M
Q3 25
$8.0M
Q2 25
$14.4M
Q1 25
$3.4M
Q4 24
$27.3M
Q3 24
$10.8M
Q2 24
$6.8M
Q1 24
$5.5M
FCF Margin
ASND
ASND
RNGR
RNGR
Q4 25
12.0%
Q3 25
6.2%
Q2 25
10.2%
Q1 25
2.5%
Q4 24
19.1%
Q3 24
7.1%
Q2 24
4.9%
Q1 24
4.0%
Capex Intensity
ASND
ASND
RNGR
RNGR
Q4 25
4.9%
Q3 25
4.3%
Q2 25
4.5%
Q1 25
5.3%
Q4 24
3.8%
Q3 24
4.5%
Q2 24
11.1%
Q1 24
4.7%
Cash Conversion
ASND
ASND
RNGR
RNGR
Q4 25
7.53×
Q3 25
11.33×
Q2 25
2.84×
Q1 25
17.67×
Q4 24
5.64×
Q3 24
2.03×
Q2 24
4.70×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASND
ASND

Segment breakdown not available.

RNGR
RNGR

High Specification Rigs$92.3M65%
Processing Solutions And Ancillary Services$37.5M26%
Wireline Services$12.4M9%

Related Comparisons